TNGX

SEC source: 0001193125-26-414500 · ownership.xml · derivative · entry 4

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 233,040

Underlying: Common Stock · 27,000 shares

Expires 2033-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

F4 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, at a rate of 25% on February 27, 2024, with the remaining option shares vesting in 36 equal monthly installments thereafter.

SEC source: 0001193125-26-414500 · ownership.xml · nonDerivative · entry 3

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 115,743

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $25.04 to $25.41 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001193125-26-414500 · ownership.xml · nonDerivative · entry 2

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,343

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $23.96 to $24.95 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001193125-26-414500 · ownership.xml · nonDerivative · entry 1

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 142,743

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

SEC source: 0001193125-26-401327 · ownership.xml · nonDerivative · entry 3

Newcomb Jessica · CIK 0002130408 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 59,121

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 23, 2026.

F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $24.59 to $25.56 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F3 · balance_after: The amount reported in Column 2 includes 43,666 unvested restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.

SEC source: 0001193125-26-401327 · ownership.xml · nonDerivative · entry 2

Newcomb Jessica · CIK 0002130408 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,521

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 23, 2026.

F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $23.52 to $24.41 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F3 · balance_after: The amount reported in Column 2 includes 43,666 unvested restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.

SEC source: 0001193125-26-401327 · ownership.xml · nonDerivative · entry 1

Newcomb Jessica · CIK 0002130408 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 66,621

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 23, 2026.

F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $22.37 to $23.32 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F3 · balance_after: The amount reported in Column 2 includes 43,666 unvested restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.

SEC source: 0001193125-26-381853 · ownership.xml · derivative · entry 3

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 260,040

Underlying: Common Stock · 27,000 shares

Expires 2033-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

F3 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, at a rate of 25% on February 27, 2024, with the remaining option shares vesting in 36 equal monthly installments thereafter.

SEC source: 0001193125-26-381853 · ownership.xml · nonDerivative · entry 2

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 115,743

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $22.08 to $22.86 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001193125-26-381853 · ownership.xml · nonDerivative · entry 1

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 142,743

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

SEC source: 0001193125-26-335002 · ownership.xml · derivative · entry 4

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 287,040

Underlying: Common Stock · 27,000 shares

Expires 2033-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

F4 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, at a rate of 25% on February 27, 2024, with the remaining option shares vesting in 36 equal monthly installments thereafter.

SEC source: 0001193125-26-335002 · ownership.xml · nonDerivative · entry 3

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 115,743

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $27.17 to $27.78 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001193125-26-335002 · ownership.xml · nonDerivative · entry 2

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 137,476

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $26.17 to $27.16 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001193125-26-335002 · ownership.xml · nonDerivative · entry 1

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 142,743

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

SEC source: 0001193125-26-295124 · ownership.xml · derivative · entry 4

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 314,040

Underlying: Common Stock · 27,000 shares

Expires 2033-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

F4 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, at a rate of 25% on February 27, 2024, with the remaining option shares vesting in 36 equal monthly installments thereafter.

SEC source: 0001193125-26-295124 · ownership.xml · nonDerivative · entry 3

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 115,743

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $29.72 to $30.65 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001193125-26-295124 · ownership.xml · nonDerivative · entry 2

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 123,114

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $28.715 to $29.71 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001193125-26-295124 · ownership.xml · nonDerivative · entry 1

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 142,743

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

SEC source: 0001193125-26-279871 · ownership.xml · derivative · entry 2

Azelby Robert · CIK 0001656998 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,910

Underlying: Common Stock · 35,910 shares

Expires 2036-06-19

F2 · derivative.exercise_date: This option shall vest and become exercisable in 36 substantially equal monthly installments over a period of three years following the grant date, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

SEC source: 0001193125-26-279871 · ownership.xml · nonDerivative · entry 1

Azelby Robert · CIK 0001656998 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,740

F1 · shares: These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in three substantially equal annual installments following the grant date, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

SEC source: 0001193125-26-262172 · ownership.xml · derivative · entry 2

Lee Sung · CIK 0001793200 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,570

Underlying: Common Stock · 3,570 shares

Expires 2036-06-05

F2 · derivative.exercise_date: This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year, with the first vesting date on July 5, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

SEC source: 0001193125-26-262172 · ownership.xml · nonDerivative · entry 1

Lee Sung · CIK 0001793200 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,870

F1 · shares: These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in their entirety on the earlier of: (i) June 5, 2027 and (ii) the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

SEC source: 0001193125-26-262227 · ownership.xml · derivative · entry 2

Ketchum John B · CIK 0001991806 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2036-06-05

F2 · derivative.exercise_date: This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year, with the first vesting date on July 5, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

SEC source: 0001193125-26-262227 · ownership.xml · nonDerivative · entry 1

Ketchum John B · CIK 0001991806 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,937

F1 · shares: These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in their entirety on the earlier of: (i) June 5, 2027 and (ii) the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

SEC source: 0001193125-26-262191 · ownership.xml · derivative · entry 2

Rothenberg Mace · CIK 0001873988 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2036-06-05

F2 · derivative.exercise_date: This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year, with the first vesting date on July 5, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

SEC source: 0001193125-26-262191 · ownership.xml · nonDerivative · entry 1

Rothenberg Mace · CIK 0001873988 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,500

F1 · shares: These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in their entirety on the earlier of: (i) June 5, 2027 and (ii) the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

SEC source: 0001193125-26-262205 · ownership.xml · derivative · entry 2

Calhoun Lesley Ann · CIK 0001730866 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2036-06-05

F2 · derivative.exercise_date: This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year, with the first vesting date on July 5, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

SEC source: 0001193125-26-262205 · ownership.xml · nonDerivative · entry 1

Calhoun Lesley Ann · CIK 0001730866 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,500

F1 · shares: These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in their entirety on the earlier of: (i) June 5, 2027 and (ii) the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

SEC source: 0001193125-26-255940 · ownership.xml · derivative · entry 4

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 341,040

Underlying: Common Stock · 27,000 shares

Expires 2033-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

F4 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, at a rate of 25% on February 27, 2024, with the remaining option shares vesting in 36 equal monthly installments thereafter.

SEC source: 0001193125-26-255940 · ownership.xml · nonDerivative · entry 3

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 115,743

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $22.60 to $23.42 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001193125-26-255940 · ownership.xml · nonDerivative · entry 2

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 136,603

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $21.58 to $22.57 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001193125-26-255940 · ownership.xml · nonDerivative · entry 1

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 142,743

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

SEC source: 0001193125-26-207096 · ownership.xml · derivative · entry 4

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 368,040

Underlying: Common Stock · 27,000 shares

Expires 2033-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

F5 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, at a rate of 25% on February 27, 2024, with the remaining option shares vesting in 36 equal monthly installments thereafter.

SEC source: 0001193125-26-207096 · ownership.xml · nonDerivative · entry 3

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 115,743

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $21.80 to $22.20 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001193125-26-207096 · ownership.xml · nonDerivative · entry 2

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,843

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $20.79 to $21.755 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

SEC source: 0001193125-26-207096 · ownership.xml · nonDerivative · entry 1

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 142,743

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

F2 · balance_after: Includes 3,121 shares that were acquired on November 1, 2025 pursuant to the Tango Therapeutics, Inc. 2021 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

SEC source: 0001193125-26-207094 · ownership.xml · derivative · entry 2

Gall Matthew · CIK 0001816194 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 240,000

Underlying: Common Stock · 240,000 shares

Expires 2036-05-01

F2 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, at a rate of 25% on April 15, 2027 with the remaining option shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

SEC source: 0001193125-26-207094 · ownership.xml · nonDerivative · entry 1

Gall Matthew · CIK 0001816194 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

F1 · shares: These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs shall vest over a three-year period at a rate of (i) 13,200 RSUs on or about May 10, 2027, (ii) 13,200 RSUs on or about May 10, 2028 and (iii) 13,600 RSUs on or about May 9, 2029, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

SEC source: 0001193125-26-201749 · ownership.xml · derivative · entry 2

Lee Sung · CIK 0001793200 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,200

Underlying: Common Stock · 5,200 shares

Expires 2036-04-29

F2 · derivative.exercise_date: This option shall vest and become exercisable in 36 substantially equal monthly installments over a period of three years commencing on January 2, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. The options were granted in connection with the Reporting Person's service on the Issuer's board of directors and reflect the value the Reporting Person is entitled to pursuant to the Issuer's Non-Employee Director Compensation Policy.

SEC source: 0001193125-26-201749 · ownership.xml · nonDerivative · entry 1

Lee Sung · CIK 0001793200 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,300

F1 · shares: These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in three substantially equal annual installments on January 2, 2027, January 2, 2028 and January 2, 2029, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. The RSUs were granted in connection with the Reporting Person's service on the Issuer's board of directors and reflect the value the Reporting Person is entitled to pursuant to the Issuer's Non-Employee Director Compensation Policy.

SEC source: 0001193125-26-159747 · ownership.xml · derivative · entry 3

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 395,040

Underlying: Common Stock · 38,460 shares

Expires 2033-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

F2 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, at a rate of 25% on February 27, 2024, with the remaining option shares vesting in 36 equal monthly installments thereafter.

SEC source: 0001193125-26-159747 · ownership.xml · nonDerivative · entry 2

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 112,622

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

SEC source: 0001193125-26-159747 · ownership.xml · nonDerivative · entry 1

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 151,082

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

SEC source: 0001193125-26-140874 · ownership.xml · derivative · entry 3

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 433,500

Underlying: Common Stock · 27,000 shares

Expires 2033-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

F3 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, at a rate of 25% on February 27, 2024, with the remaining option shares vesting in 36 equal monthly installments thereafter.

SEC source: 0001193125-26-140874 · ownership.xml · nonDerivative · entry 2

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 112,622

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.69, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001193125-26-140874 · ownership.xml · nonDerivative · entry 1

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 139,622

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

SEC source: 0001193125-26-129990 · ownership.xml · derivative · entry 3

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 460,500

Underlying: Common Stock · 12,000 shares

Expires 2033-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

F3 · derivative.exercise_date: This option shall vest and become exercisable over a four-year period, at a rate of 25% on February 27, 2024, with the remaining option shares vesting in 36 equal monthly installments thereafter.

SEC source: 0001193125-26-129990 · ownership.xml · nonDerivative · entry 2

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 112,622

F2 · kind: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.27, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.27, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001193125-26-129990 · ownership.xml · nonDerivative · entry 1

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,622

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.

SEC source: 0001193125-26-098443 · ownership.xml · nonDerivative · entry 1

Crystal Adam · CIK 0001825445 · President, R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 112,622

F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.